Which medication is commonly prescribed alongside beta blockers for angina management?

Beta blockers are frequently prescribed for angina management due to their ability to decrease heart rate, reduce myocardial oxygen demand, and ultimately improve symptoms associated with angina. While beta blockers can be effective on their own, they may sometimes be combined with other medications to optimize treatment and provide additional relief for patients.

Ranolazine is an antianginal medication that works through a different mechanism than beta blockers. It primarily acts by inhibiting the late sodium current in cardiac myocytes, which reduces intracellular sodium and calcium overload. This can help improve myocardial perfusion and reduce angina episodes. The addition of ranolazine to a beta blocker regimen can enhance the overall effectiveness of angina treatment, particularly in patients who remain symptomatic despite adequate beta-blocker therapy. This combination allows for better management of angina by addressing multiple pathways contributing to the condition.

Aspirin is commonly used for its antiplatelet effects in patients with coronary artery disease, while furosemide is a diuretic used primarily for heart failure and fluid retention. Digoxin is used for heart rate control and is more relevant in certain types of heart rhythm disorders rather than directly for angina management. Therefore, ranolazine stands out as the appropriate choice to augment the therapeutic effects of